专注于肠道微生物:癌症治疗的新方向
Lingshan Liao1, Mengying Zeng2, Debei Liu2
1Department of Pathology, Changde Hospital, Xiangya School of Medicine, Central South University, Changde, China.
Frontiers in oncology
|September 15, 2025
概括
肠道微生物显著影响癌症治疗的有效性和副作用. 了解这些相互作用是开发个性化微生物组疗法以更好地治疗癌症的关键.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群在癌症治疗中起着至关重要的作用.
- 微生物的影响扩展到包括化疗,免疫疗法和放射治疗在内的各种治疗方法.
- 特定的微生物种群及其代谢物调节治疗疗效和毒性.
研究的目的:
- 审查肠道微生物群在癌症治疗中的多方面的作用.
- 探索肠道微生物影响治疗结果的机制.
- 讨论基于微生物组的癌症干预措施的当前挑战和未来方向.
主要方法:
- 对研究肠道微生物群和癌症治疗的文献综述.
- 分析包括代谢重编程,免疫调节和瘤微环境重塑在内的机制.
- 综合关于微生物干预的发现及其临床转化.
主要成果:
- 肠道微生物可以增强或阻碍癌症治疗的疗效和毒性.
- 相互作用取决于背景,受到饮食,地理和宿主免疫的影响.
- 微生物干预有希望,但在临床应用中面临挑战.
结论:
- 基于微生物组的个性化策略对于优化癌症治疗至关重要.
- 需要进一步的研究来澄清因果机制,并建立临床指南.
- 跨学科的方法对于将肠道微生物群作为癌症治疗中的共同目标来整合至关重要.
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


